http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017204231-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-51 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-51 |
| filingDate | 2017-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2017204231-A1 |
| titleOfInvention | Therapeutic agents for brain disorders including umbilical cord-derived cells |
| abstract | In brain damage caused by cerebral hemorrhage or ischemia, it is necessary not only to cure the hemorrhage or ischemia that is the cause but also to promote protection or regeneration of nerve cells or the like damaged by the cause. Therefore, an object of the present invention is to provide umbilical cord-derived cells having an effect of promoting the protection or regeneration of such nerve cells and the like. Another object of the present invention is to provide a therapeutic agent for brain disorders which is effective by a more easy administration route. The present invention is a therapeutic agent for brain damage, which comprises umbilical cord-derived cells. In addition, the therapeutic agent of the present invention is preferably for intravenous administration. Furthermore, the umbilical cord-derived cells are preferably cells prepared from umbilical cord tissue including amniotic membrane, blood vessels, perivascular tissues and Wharton's jelly. |
| priorityDate | 2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 631.